Skip to content
Home/Companies/HealthTech/Groupe Bioclinic
GB

Groupe Bioclinic

HealthTech·France·Exited 2022·Held 3yr

GROUPE BIOCLINIC is a healthcare company, headquartered in France.

Entry
2019
Hold
3yr
Exit
2022
Est. EV
–

Who owns Groupe Bioclinic?

Groupe Bioclinic was owned by Socadif through SOCADIF (1991 vintage) from 2019 to 2022, exited via Trade Sale. Across its history, Groupe Bioclinic has been through 2 private equity ownership periods, detailed in the timeline below.

Buyer identity available on Pro.

Hand-verified · updated 2026-05-07

Socadif
Most recent investor
Socadif
SOCADIF · 1991 · Growth
2 ownership periods · full history below

Key facts

HQFrance
SectorHealthcare
StatusAcquired
Key takeaways
  • ·Fully exited in 2022.
  • ·Average hold across 2 realized cycles: 3 years.

Ownership history

2 ownership periods · co-invest detected

Exited
Last exited in 2022 to .
Co-invest · 2 holders · 2019 · 2022
Idia
IdiaExited 2022
2019 · 2022 · IDIA Small & Midcap · 1990 · Buyout
Trade Sale · to
MOIC
–
Socadif
SocadifExited 2022
2019 · 2022 · SOCADIF · 1991 · Growth
Trade Sale · to
MOIC
–

More from SOCADIF

Other portfolio companies in the same fund.

Apartments-WS
Active
HospitalityFrance
Bijoux CN
Active
ConsumerFrance
Cybstores
Active
France
Delpharm
Active
PharmaFrance
Demeco
Active
LogisticsFrance
Ekkia
Active
ConsumerFrance

More PE-backed in HealthTech

Comparable healthtech deals from other GPs.

CIGA Healthcare
Active
Clarendon Fund ManagersUK
Paladin
Active
Ring CapitalFrance
Theraclion
Exited 2014
KaristaFrance
to
Access Infinity
Active
CBPE CapitalUK· 2026
Brightheart
Active
Odyssée VentureFrance· 2026
Dermascan
Active
Ring CapitalFrance· 2026
Data refreshed weekly · Sourced from public filings